Paxlovid Boceprevir Intermediate CAS 565456-77-1 Intende ≥99.0%
Commercial Supple PF-07321332 Paxlovid Intermedia cum High Quality
L-tert-Leucine (H-Tle-OH) CAS 20859-02-3
Caronic Anhydride CAS 67911-21-1
(1R,2S,5S)-6,6-Dimethyl-3-azabicyclo[3.1.0]hexane-2-Carboxylic Acid Methyl Ester Hydrochloride 565456-77-1
Methyl(S)-2-(Boc-amino)-3-[(S)-2-oxo-3-pyrrolidinyl]propanoate CAS 328086-60-8
6,6-Dimethyl-3-azabicyclo[3.1.0]hexane CAS 943516-54-9
Nomen chemicum | (1R,2S,5S)-6,6-Dimethyl-3-azabicyclo[3.1.0]hexane-2-Carboxylic Acidum Methyl Ester hydrochloridum |
Synonyma | Methyl (1R,2S,5S)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxylatus hydrochloride |
CAS Number | 56545-77-1 |
CATTUS Number | RF-PI318 |
Stock Status | In Stock, Productio Ascendite ad Tons |
Formulae hypotheticae | C9H15NO2.ClH |
M. Pondus | 205.683 |
Brand | Ruifu Chemical |
Item | Specifications |
Aspectus | Alba ad Off-White pulveris |
Lepidium sativum | IR: Similia Reference substantia |
Lepidium sativum B * | Retention tempus: Similia Reference substantia |
Enantiomer | ≤0.15% |
Related immunditiam (per HPLC) | |
Ignota immunditia | ≤0.20% |
Totalis immunditias | ≤1.0% |
Aqua | ≤0.50% |
Residere in Ignition | ≤0.10% |
Metalla gravis | ≤20ppm |
Assay | ≥99.0% |
Test Standard | Enterprise Standard |
Consuetudinem | Intermedium PF-07321332 Paxlovid (CAS 2628280-40-8) et Boceprevir (CAS 394730-60-0); |
sarcina: Utrem, aluminium foil, pera, cardboard tympanum, 25kg/Drum, vel secundum exigentiam emptoris.
Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine, humore et pestis infestatione.
(1R,2S,5S) -6,6-Dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxylicus acidum Methyl Ester hydrochloridum (CAS 565456-77-1) est derivativum azabicyclohexanum in praeparatione hepatitis C adhibitum. virus (HCV) NS3 serine protease inhibitor.Medium illud est PF-07321332 Paxlovid (CAS 2628280-40-8) et Boceprevir (CAS 394730-60-0).PF-07321332 potens et viva voce SARS-CoV 3C sicut protease (3CLPRO) inhibitor.PF-07321332 scuta ad virum SARS-CoV-2 et pro COVID-19 reseacrch adhiberi possunt.Boceprevir (INN, nomen artis Victrelis) est protease inhibitor adhibitus ut curatio hepatitis C genotypi 1. Ligat ad HCV instructura 3 NS3 (HCV) situs activus.Proventus a Schering-Pough erat, sed nunc a Merck cum Schering anno 2009 acquiritur. Probatum est a FDA die 13 mensis Maii anno 2011 .